4.8 Article

Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops

Journal

CIRCULATION
Volume 143, Issue 24, Pages 2384-2394

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.120.051683

Keywords

barbering; blood pressure; cost-benefit analysis; hypertension

Funding

  1. Health Resources and Services Administration (HRSA) [T32 HP10260]
  2. National Heart, Lung, and Blood Institute (NHLBI), Bethesda, MD [R01 HL130500-01A1, R01 HL139837, K23 HL136899, K23 HL153888, K01 HL140170]
  3. National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK10862805S1]
  4. NHLBI [K01 HL151974, R01 HL 117983]
  5. NIH National Center for Advancing Translational Sciences UCLA Clinical and Translational Science Institute [UL1 TR 001881]
  6. California Endowment [20131872, 20162257]
  7. Lincy Foundation
  8. Harriet and Steven Nichols Foundation
  9. Burns and Allen Chair in Cardiology Research at the Smidt Heart Institute
  10. Division of Community Relations and Development at Cedars-Sinai Medical Center

Ask authors/readers for more resources

The pharmacist-led hypertension care in Black barbershops in Los Angeles County significantly improved blood pressure control in non-Hispanic Black men. The 10-year projection showed that this intervention was highly cost-effective, with an average cost of $42,717 per QALY gained.
Background: In LABBPS (Los Angeles Barbershop Blood Pressure Study), pharmacist-led hypertension care in Los Angeles County Black-owned barbershops significantly improved blood pressure control in non-Hispanic Black men with uncontrolled hypertension at baseline. In this analysis, 10-year health outcomes and health care costs of 1 year of the LABBPS intervention versus control are projected. Methods: A discrete event simulation of hypertension care processes projected blood pressure, medication-related adverse events, fatal and nonfatal cardiovascular disease events, and noncardiovascular disease death in LABBPS participants. Program costs, total direct health care costs (2019 US dollars), and quality-adjusted life-years (QALYs) were estimated for the LABBPS intervention and control arms from a health care sector perspective over a 10-year horizon. Future costs and QALYs were discounted 3% annually. High and intermediate cost-effectiveness thresholds were defined as <$50 000 and <$150 000 per QALY gained, respectively. Results: At 10 years, the intervention was projected to cost an average of $2356 (95% uncertainty interval, -$264 to $4611) more per participant than the control arm and gain 0.06 (95% uncertainty interval, 0.01-0.10) QALYs. The LABBPS intervention was highly cost-effective, with a mean cost of $42 717 per QALY gained (58% probability of being highly and 96% of being at least intermediately cost-effective). Exclusive use of generic drugs improved the cost-effectiveness to $17 162 per QALY gained. The LABBPS intervention would be only intermediately cost-effective if pharmacists were less likely to intensify antihypertensive medications when systolic blood pressure was >= 150 mm Hg or if pharmacist weekly time driving to barbershops increased. Conclusions: Hypertension care delivered by clinical pharmacists in Black barbershops is a highly cost-effective way to improve blood pressure control in Black men.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available